Continuous Proton Pump Inhibitor Therapy and the Associated Risk of RecurrentClostridium difficileInfection-Reference-Cited by-同舟云学术

Continuous Proton Pump Inhibitor Therapy and the Associated Risk of RecurrentClostridium difficileInfection

Published:2015-05-01 Issue:5 Volume:175 Page:784
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

McDonald Emily G.¹,Milligan Jonathon²,Frenette Charles³,Lee Todd C.⁴

Affiliation:

1. Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada2McGill Centre for Quality Improvement, Montreal, Quebec, Canada

2. Department of Medicine, University of Toronto, Toronto, Ontario, Canada

3. Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada

4. Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada2McGill Centre for Quality Improvement, Montreal, Quebec, Canada4Division of Infectious Diseases, Department of Medicine, McGill Univer

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Cited by 189 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cost of potentially inappropriate medications for older adults in Canada: A comparative cross‐sectional study;Journal of the American Geriatrics Society;2024-09-05

2. Pathogenesis and therapeutic opportunities of gut microbiome dysbiosis in critical illness;Gut Microbes;2024-05-23

3. Rebound Acid Hypersecretion after Withdrawal of Long-Term Proton Pump Inhibitor (PPI) Treatment—Are PPIs Addictive?;International Journal of Molecular Sciences;2024-05-17

4. Approach to the diagnosis and management of dysbiosis;Frontiers in Nutrition;2024-04-19

5. Side effects of proton pump inhibitors: how real are they in clinical practice?;Clinical Medicine (Russian Journal);2024-04-15